Device Trial Radar · NCT03739216
Registry of Subject Treated With ClariFix
Last checked: Nov 20, 2026Latest source record: Aug 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
354
Actual
Start
Jun 13, 2018
Primary completion
Jun 15, 2021
Study completion Jun 15, 2021
Sponsor
- Lead sponsor
- Arrinex, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 13, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A multi-center, prospective, non-randomized, observational registry to asses the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.
Conditions
- Chronic Rhinitis
Interventions
ClariFixDevice
The ClariFix device is a handheld cryosurgical device which provides focal, controlled freezing to the target tissue.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in nasal symptom severityTime frame: Follow-up visits at 6 weeks, 3, 6, 9, 12, 15, 18, 21, and 24 months post treatment
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Del Rey Allergy & Sinus
Bakersfield, California
Del Rey Allergy & Sinus
Marina del Rey, California
Sacramento, Ear, Nose, and Throat
Roseville, California
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.